Results 91 to 100 of about 1,490 (145)

Serum gastrin concentrations in dogs with primary hyperparathyroidism. [PDF]

open access: yesJ Vet Intern Med
Vose J   +9 more
europepmc   +1 more source

Neuropeptidergic systems in psychiatric disorders. [PDF]

open access: yesFront Endocrinol (Lausanne)
Hodzic S, Riedemann T.
europepmc   +1 more source

Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Holzleitner N   +10 more
europepmc   +1 more source

Radiopharmaceutical formulation and preliminary clinical dosimetry of [<sup>177</sup>Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Zavvar TS   +12 more
europepmc   +1 more source

Clinicopathological Correlates of Hormone Expression-Based Subtypes of Non-Functioning Duodenal/Ampullary Neuroendocrine Tumors: A Multicenter Study of 151 Cases. [PDF]

open access: yesEndocr Pathol
Vanoli A   +24 more
europepmc   +1 more source

Gastrins in Serum

Scandinavian Journal of Gastroenterology, 1973
Jens Rehfeld
exaly   +3 more sources

Gastrin: a review

Current Medical Research and Opinion, 1974
SummaryDespite isolation in pure form, full chemical characterisation, synthetic production and sophisticated assay technique, the foregut hormone gastrin is probably still as great an enigma today as regards its role in disease as it was when Edkins first postulated its existence nearly 70 years ago.The authors review the recent work on the hormone ...
P J, Rooney, D, Grennan, J, Millar
openaire   +2 more sources

Radioimmunoassay of Gastrin: Specificity of Gastrin Antisera

Scandinavian Journal of Gastroenterology, 1969
Antisera for use in a gastrin radioimmunoassay have been prepared in two ways and their specificity compared. Antibodies to porcine antral gastrin were found to be specific for the N-terminal portion of the molecule; there was no cross-reaction with pentagastrin or pancreozymin.
openaire   +2 more sources

Home - About - Disclaimer - Privacy